Informatie:
Fout:
ID
31847
Beschrijving
A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00713544
Link
https://clinicaltrials.gov/show/NCT00713544
Trefwoorden
Versies (1)
- 02-10-18 02-10-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
2 oktober 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Rheumatoid Arthritis NCT00713544
Eligibility Rheumatoid Arthritis NCT00713544
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00713544
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Rheumatoid Arthritis | Swollen joint count | Tender joint count | Elevated erythrocyte sedimentation rate (ESR) Hematologic Test | Elevated C-reactive protein Hematologic Test
Item
diagnosis of ra with active disease defined as: ≥4 swollen joints and ≥6 tender/painful joints, and either have (blood tests) elevated erythrocyte sedimentation rate (esr) or c-reactive protein (crp).
boolean
C0003873 (UMLS CUI [1])
C0451521 (UMLS CUI [2])
C0451530 (UMLS CUI [3])
C1867037 (UMLS CUI [4,1])
C0018941 (UMLS CUI [4,2])
C0742906 (UMLS CUI [5,1])
C0018941 (UMLS CUI [5,2])
C0451521 (UMLS CUI [2])
C0451530 (UMLS CUI [3])
C1867037 (UMLS CUI [4,1])
C0018941 (UMLS CUI [4,2])
C0742906 (UMLS CUI [5,1])
C0018941 (UMLS CUI [5,2])
Rheumatoid factor positive Hematologic Test | Bone erosion Radiographic | Anti-cyclic citrullinated peptide antibody Hematologic Test
Item
at least one of the following: documented history of positive rheumatoid factor (blood test), current presence of positive rheumatoid factor (blood test), baseline radiographic erosion, presence of serum anti-cyclic citrullinated peptide antibodies (bloo
boolean
C0151379 (UMLS CUI [1,1])
C0018941 (UMLS CUI [1,2])
C0587240 (UMLS CUI [2,1])
C0444708 (UMLS CUI [2,2])
C2210597 (UMLS CUI [3,1])
C0018941 (UMLS CUI [3,2])
C0018941 (UMLS CUI [1,2])
C0587240 (UMLS CUI [2,1])
C0444708 (UMLS CUI [2,2])
C2210597 (UMLS CUI [3,1])
C0018941 (UMLS CUI [3,2])
Methotrexate Oral Tablet | Subcutaneous injection of methotrexate
Item
be receiving either: oral (tablets) or subcutaneous (injection) methotrexate for at least 6 months prior to randomisation.
boolean
C1246896 (UMLS CUI [1])
C2585798 (UMLS CUI [2])
C2585798 (UMLS CUI [2])
Inflammatory disorder In addition to Rheumatoid Arthritis | Interference Clinical Trial | Polymyalgia Rheumatica | Giant Cell Arteritis | Arthritis, Reactive
Item
any other inflammatory disease in addition to ra that may interfere with the study (e.g. polymyalgia rheumatica, giant cell arteritis, reactive arthritis, etc).
boolean
C1290884 (UMLS CUI [1,1])
C0332287 (UMLS CUI [1,2])
C0003873 (UMLS CUI [1,3])
C0521102 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0032533 (UMLS CUI [3])
C0039483 (UMLS CUI [4])
C0085435 (UMLS CUI [5])
C0332287 (UMLS CUI [1,2])
C0003873 (UMLS CUI [1,3])
C0521102 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0032533 (UMLS CUI [3])
C0039483 (UMLS CUI [4])
C0085435 (UMLS CUI [5])
Chronic pain | Fibromyalgia | Chronic Fatigue Syndrome
Item
current chronic pain disorders including fibromyalgia and chronic fatigue syndromes.
boolean
C0150055 (UMLS CUI [1])
C0016053 (UMLS CUI [2])
C0015674 (UMLS CUI [3])
C0016053 (UMLS CUI [2])
C0015674 (UMLS CUI [3])